Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial - Top-Institutions - MDSpire

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial

  • By

  • Hiroshi Ureshino

  • Kazunori Murai

  • Takashi Kumagai

  • Tatsuji Mino

  • Kaichi Nishiwaki

  • Satoshi Wakita

  • Tomoharu Takeoka

  • Masayuki Mita

  • Chikashi Yoshida

  • Nobuhiko Uoshima

  • Toshihiro Fukushima

  • Junya Kuroda

  • Takeshi Kondo

  • Masahiro Chiba

  • Takuya Miyazaki

  • Katsuhiro Io

  • Tomoaki Ueda

  • Takaaki Ono

  • Kensuke Usuki

  • Takahiro Yamauchi

  • Katsumichi Fujimaki

  • Takayuki Ikezoe

  • Atsushi Kawaguchi

  • Shinya Kimura

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Saga University
    Saga University

    Saga, Saga

    Key Differentiators

    • Hematology

  • #2

    University of Rochester
    University of Rochester

    Rochester, New York

    Key Differentiators

    • Hematology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology

  • #4

    Universitätsklinikum Jena
    Universitätsklinikum Jena

    Jena, Thuringia

    Key Differentiators

    • Hematology

  • #5

    Princess Margaret Hospital
    Princess Margaret Hospital

    Toronto, Ontario

    Key Differentiators

    • Hematology

Original Source(s)

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial

  • by Hiroshi Ureshino, Kazunori Murai, Takashi Kumagai, Tatsuji Mino, Kaichi Nishiwaki, Satoshi Wakita, Tomoharu Takeoka, Masayuki Mita, Chikashi Yoshida, Nobuhiko Uoshima, Toshihiro Fukushima, Junya Kuroda, Takeshi Kondo, Masahiro Chiba, Takuya Miyazaki, Katsuhiro Io, Tomoaki Ueda, Takaaki Ono, Kensuke Usuki, Takahiro Yamauchi, Katsumichi Fujimaki, Takayuki Ikezoe, Atsushi Kawaguchi, Shinya Kimura

  • May 28, 2026

Related Content

From AI-based image analysis to surgical decision support in prostate cancer: interdisciplinary application of the international radiomics platform

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Association between adenomyosis subtypes and concurrent endometrial lesions: a propensity score-matched retrospective study